NATIONAL STOCK EXCHANGE OF INDIA LIMITED DEPARTMENT : SURVEILLANCE Download Ref No : NSE/SURV/37026
Date : February 22, 2018
Circular Ref. No : 40/2018
To All Members, Sub: Derivatives contracts in Fortis Healthcare Limited (FORTIS) Members are hereby intimated that, so far FORTIS has failed to submit its quarterly financial results for quarter ended September 2017 and December 2017. FORTIS vide its letter no FHL/SEC/STEX/RR/2017-18 dated February 13, 2018 has intimated that its Board shall consider the financial results of September 2017 and December 2017 in its meeting to be held on February 28,2018. In case FORTIS fails to submit to the Exchange the financial results duly considered and approved by March 01,2018 then Exchange in exercise of its power granted under SEBI circular no. SMDRP/DC/CIR-13/02 dated December 18, 2002 shall exclude FORTIS from Equity derivative segment. Accordingly all the existing Futures and Options contracts, across all expiries shall expire on March 28, 2018. No Futures and Options contracts shall be available in FORTIS for trading in Equity derivatives segment from March 29, 2018 onwards.
For and on behalf of National Stock Exchange of India Limited Avishkar Naik Assistant Vice President
Telephone No. +91-22-26598129/26598166
Email id
[email protected]
Regd. Office: Exchange Plaza, Plot No. C/1, G-Block, Bandra-Kurla Complex, Bandra (E), Mumbai 400 051, India. CIN: U67120MH1992PLC069769 · Tel: +91 22 26598129 / 022-26598166 · Web site: www.nseindia .com